HOME >> BIOLOGY >> NEWS
Pan-African Malaria Conference November 17-22 in Arusha, Tanzania

National Institutes of Health, Bethesda, Maryland -- The Fogarty International Center (FIC) of the National Institutes of Health (NIH) announces the Third Pan-African Malaria Conference of the Multilateral Initiative on Malaria (MIM). The MIM conference, now open to members of the media, will be held November 17 to 22, 2002, in Arusha, Tanzania.

The MIM conference will bring together malaria researchers from across Africa and around the world to consider malaria research advances, how to more effectively employ or develop malaria-control strategies, and how to strengthen malaria research training activities. More than 700 malaria researchers and control experts will attend the MIM conference.

MIM is an international alliance of research and public health agencies and African scientists established in 1997 in Dakar, Senegal, at the first Pan-African Malaria Conference. MIM's objectives are to stimulate and support collaborative research to address the needs of public health programs in malaria-endemic countries and to strengthen research capacity in malaria-endemic countries. FIC, which serves as the current MIM Secretariat, organized the conference on behalf of the MIM partners.

Public and private groups are co-sponsoring the conference. Major sponsors include the NIH (the Fogarty International Center, the National Institute of Allergy and Infectious Diseases, the National Institute of Environmental Health Sciences, and the National Library of Medicine), the Bill & Melinda Gates Foundation, GlaxoSmithKline, the German Federal Ministry for Education and Research, the Malaria Vaccine Initiative, the Swiss Development Cooperation, the United States Agency for International Development, the World Health Organization, The Wellcome Trust, and the UK Medical Research Council. A complete list of partners is available on the MIM website at http://mim.nih.gov.

Malaria kills 2.7 million people each year, mo
'"/>

Contact: Irene Edwards
edwardsi@mail.nih.gov
301-496-2075
NIH/Fogarty International Center
16-Oct-2002


Page: 1 2

Related biology news :

1. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
2. Malaria rise in Africa parallels warming trends
3. Multilateral Initiative on Malaria Secretariat to move to Sweden
4. Malaria research and training benefits global community
5. Malaria called failure, puzzle and challenge
6. Multicomponent Malaria Vaccine Shows Promise in Laboratory Tests
7. Christmas Travellers Are Warned Of Malaria Risks
8. Genetic Code Of Chromosome Of Malaria Parasite Deciphered
9. Virginia Tech Scientist Seek Genetic Solution To Malaria
10. Severe Falciparum Malaria Increases In Honduras
11. Curing Malaria, Controlling Mosquitoes Symposium Set For AAAS Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pan African Malaria Conference November Arusha Tanzania

(Date:3/2/2015)... Calif. , March 2, 2015 ... leading developer of human interface solutions, today announced ... that is designed to enable rapid and secure ... ID™ module for gaming is a turnkey solution ... the ability to quickly integrate fingerprint ID solutions ...
(Date:3/2/2015)... , March 2, 2015  Businesses have a ... protection company Tharon Rankins Enterprises has announced the ... an ultra-safe way for businesses to protect their ... transactions. Beconux is a biometric ... Enterprises. Functioning similarly to an ATM machine, the ...
(Date:3/2/2015)... --  Neurotechnology , a provider of high-precision biometric, robotics ... Development Kit (SDK). The SentiGaze algorithm enables designers ... to track eye movements and generate heatmaps based on ... be used for applications such as analysis of websites ... can also be used to develop interfaces for a ...
Breaking Biology News(10 mins):Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Personal Data Protection Company Launches New Product 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3
(Date:3/2/2015)... Analyzing a puzzling multisystem disorder in ... syndrome, shedding light on key biological processes during ... to help caregivers manage the disorder, and may ... "This syndrome illuminates a very important pathway in ... controls many other genes," said study leader ...
(Date:3/2/2015)... 2, 2015 Editor Note: For ...   Moments ago, Analysts Review released new research ... (NASDAQ: SSH ), Synergetics USA ... ELOS ), Spectranetics (NASDAQ: SPNC ), ... a single unified platform for investors, to hear about what ...
(Date:3/2/2015)... 2015 Outside GC, the leading provider ... addition of Debbie Casey as a member of the ... space. , Debbie has spent over 20 ... Fresenius Medical Care North America in both legal and ... to work with Outside GC’s growing list of healthcare ...
(Date:2/27/2015)... , Feb. 27, 2015  Pharmacyclics, Inc. ... longer-term toxicology studies for its newly developed Bruton,s ... RA, have been completed. The results of these ... Food and Drug Administration. The feedback received from ... the ongoing first-in-human study. Additional preclinical work is ...
Breaking Biology Technology:New Genetic Syndrome Found, Arising from Errors in 'Master Switch' During Early Development 2New Genetic Syndrome Found, Arising from Errors in 'Master Switch' During Early Development 3New Genetic Syndrome Found, Arising from Errors in 'Master Switch' During Early Development 4Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4Outside GC Expands Healthcare Team 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3
Cached News: